BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4633099)

  • 1. The fibrinolytic enzyme system in leukaemia, myelomatosis and myeloproliferative diseases.
    Ogston D; Dawson AA; Adam HM
    Acta Haematol; 1972; 48(6):322-30. PubMed ID: 4633099
    [No Abstract]   [Full Text] [Related]  

  • 2. The fibrinolytic enzyme system in haematological malignancy.
    Dawson AA; Ogston D; Douglas AS
    Bibl Anat; 1973; 12():272-8. PubMed ID: 4597632
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolysis in myelomatosis.
    Preston FE; Lee D
    Acta Haematol; 1972; 47(2):65-70. PubMed ID: 4623361
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulation studies of menopausal women taking estrogen replacement.
    Beller FK; Nachtigall L; Rosenberg M
    Obstet Gynecol; 1972 May; 39(5):775-8. PubMed ID: 4260072
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis in leukaemia.
    Ogston D; McAndrew GM; Ogston CM
    J Clin Pathol; 1968 Mar; 21(2):136-9. PubMed ID: 5246740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell acetylcholinesterase activity and lysis in various dyshaemopoietic disorders.
    Stathakis N; Papayannis AG; Scliros P; Gardikas C
    Scand J Haematol; 1973; 11(3):210-6. PubMed ID: 4765536
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of patients with increased fibrinolytic split products (FSP) in their serum.
    Cooper HA; Bowie EJ; Owen CA
    Mayo Clin Proc; 1974 Sep; 49(9):654-7. PubMed ID: 4413314
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood coagulation and fibrinolysis in acute leukaemia.
    Brakman P; Snyder J; Henderson ES; Astrup T
    Br J Haematol; 1970 Feb; 18(2):135-45. PubMed ID: 4245344
    [No Abstract]   [Full Text] [Related]  

  • 9. Bleeding complications and coagulopathy in acute leukaemia.
    Törnebohm E; Blombäck M; Lockner D; Egberg N; Paul C
    Leuk Res; 1992 Oct; 16(10):1041-8. PubMed ID: 1405706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure in myelomatosis from intravascular coagulation.
    Preston FE; Ward AM
    Br Med J; 1972 Mar; 1(5800):604-5. PubMed ID: 5013834
    [No Abstract]   [Full Text] [Related]  

  • 11. On coagulation and fibrinolysis in renal failure.
    Larsson SO
    Scand J Haematol Suppl; 1971; 15():1-59. PubMed ID: 5284430
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disseminated intravascular coagulation (D.I.C.) and fibrinolysis in patients with acute leukemia (author's transl)].
    Bunjevacki G; Sultan Y; Izraël V
    Nouv Rev Fr Hematol (1978); 1978; 20(4):575-84. PubMed ID: 752151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
    Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation abnormalities in patients with inoperable lung cancer.
    Hagedorn AB; Bowie EJ; Elveback LR; Owen CA
    Mayo Clin Proc; 1974 Sep; 49(9):647-53. PubMed ID: 4278033
    [No Abstract]   [Full Text] [Related]  

  • 15. Disorders of fibrinolysis.
    Kwaan HC
    Med Clin North Am; 1972 Jan; 56(1):163-76. PubMed ID: 4550188
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolysis and antithrombin in acute leukaemia.
    Laursen B
    Dan Med Bull; 1976 May; 23(2):81-6. PubMed ID: 59658
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of immune complexes on coagulation and fibrinolysis in vivo.
    Simpson JG; Robertson AJ; Stalker AL
    Bibl Anat; 1973; 12():260-6. PubMed ID: 4790360
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disseminated intravascular coagulation in blastic leukemia and certain other disorders].
    Génova V; Georgief Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(2):300-12. PubMed ID: 4136341
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fibrinolytic enzyme system in malignant lymphomas.
    Ogston D; Dawson A
    Acta Haematol; 1973; 49(2):89-95. PubMed ID: 4196481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.